All News

The investigators analyzed a panel of antibodies generated in response to the Pfizer COVID-19 vaccine and found that delta was unable to evade all but 1 of the antibodies tested.

In clinical trials, empagliflozin significantly reduced the relative risk of the primary composite endpoint of time to cardiovascular death or hospitalization for heart failure by 25%.

CMS reported that 3.3 million more Medicare Part D beneficiaries with complex health needs than expected between 2013-2018 received a comprehensive medication review as a part of medication therapy management

In the sixth part of the series, students discussed how their involvement in pandemic-related vaccinations or aid efforts affected how they viewed the field and their role in the field.

According to the investigators, both trials demonstrated an overall well-tolerated safety profile for brolucizumab.

Specialty pharmacists’ roles have grown in new and exciting ways in recent years, and those changes have directly impacted health outcomes for all specialty patients, including patients with HIV.

According to Fenn, these numbers are significant when considering the types of errors that are likely to occur in sleep-deprived operators, such as surgeons or police officers, and the 4% decrease in errors could potentially save lives.

It is now the only 4-dose-a-year biologic for psoriasis with options to administer via a single-dose pen or prefilled syringe, the company said.

Severe persistent asthma is the worse type of asthma.

Expectations for pharmacists related to drug utilization reviews lead to examination of woman's death.

Widespread COVID-19 booster shot administration is pending FDA approval and recommendation by the Advisory Committee on Immunization Practices.

A proactive approach can ensure that the patient is getting the right therapy at the right time and the right treatment plan with the least amount of waste.

The continued approval for this indication may be subject upon verification and description of clinical benefit in a confirmatory trial.

Approved by the FDA on June 29, 2020, the pertuzumab, trastuzumab, and hyaluronidase-zzxf combination therapy with chemotherapy offers several advantages to the standard treatment of pertuzumab plus trastuzumab with chemotherapy for breast cancers with HER2 overexpression.

These findings could lead to improved therapies and prolonged survival for patients with metastatic TNBC, according to the study authors.

New roles and responsibilities can be passed to pharmacy technicians in order to free up pharmacists’ time, which enables them to be more engaged with their patients and provide more direct patient care.

English discussed the challenges and highlights of her time in the trial, in addition to what she feels health care professionals should learn from her own treatment experience.

Dennis Wright, senior director of product marketing for Central Pharmacy Compounding and Dispensing at Omnicell, discusses methods of addressing the rising rate of hospital pharmacist burnout through automation and technology-enabled services.

What many preceptors may not realize is that in addition to learning about practice settings, all graduates of pharmacy schools in the United States must also be able to demonstrate leadership, innovation, and entrepreneurship.

Amesh Adalja, MD, FIDSA, FACP, FACEP, said that the efficacy of COVID-19 booster vaccines against variants of concern is still relatively unknown, although administering the third shots does increase antibodies as expected.

Ten quiz questions to assess your knowledge on common dyslipidemia treatments.

Non-alcoholic steatohepatitis is the most severe form of non-alcoholic fatty liver disease.

Semaglutide is a once weekly subcutaneous injection that was granted FDA approval for use in adults with obesity or overweight with at least one other weight related-condition.

COVID-19 vaccination opportunities will likely be present for years to come.

The FDA has approved Qelbree (viloxazine extended-release capsules; Supernus Pharmaceuticals, Inc) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in pediatric patients aged 6 to 17 years.

Alembic Pharmaceuticals, Inc in Bridgewater, NJ is a subsidiary of Alembic Pharmaceuticals Ltd., the oldest pharmaceutical company in India, employing more than 12,000 people.

Atrial fibrillation, bleeding, infection, and other adverse events may occur with this therapy.